Premium
P4–160: Stability performance of a fully automated, chemiluminescent tau assay for the VITROS ® immunodiagnostic systems with cerebrospinal fluid over a 29‐week study
Author(s) -
DiMagno Lisa,
Jackson Shari,
Tweedie Anne,
Ackles Karen,
Byrne Deb,
Kozo Daniel,
Baburina Irina,
Salamone Salvatore,
Soares Holly,
Berisha Flora,
Neely Robert,
Green George
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.1551
Subject(s) - cerebrospinal fluid , chemiluminescence , reagent , medicine , chromatography , chemistry
Major depression 17,9% (14) 4,1% (4) 0,003 Dyshthymia 21,8% (17) 9,2% (9) 0,019 Minor depresion 19,2% (15) 3,1% (3) <0,001 Panic disorder 1,3% (1) 3,1% (3) 0,431 Generalized anxiety disorder 5,1% (5) 13,3% (13) 0,481 Anxiety not specified 32,1% (25) 13,3% (13) 0,003 Somatoform disorder 20,5% (16) 5,1% (5) 0,002 Somatoform disorder not specified 35,9% (28) 19,4% (19) 0,014 Persistent somatoform pain disorder 37,2% (29) 5,1% (5) <0,001 Percentage (cases)